Annovis Bio, Inc. (ANVS) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 71.11M |
| Enterprise Value | 51.58M |
| P/E Ratio | -0.66 |
| PEG Ratio | 0.59 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -10.49 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.65 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.25 |
| Return On Equity | -6.86 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -28.85M |
| Net Income | -28.85M |
| Diluted EPS | -1.4 |
Balance Sheet
| Total Cash | 18.73M |
| Total Cash/Share | 0.5 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.95 |
| Book Value Per Share | -0.11 |
Price History
| 52-Week Change | -44.37 |
| 52-Week High | 5.5 |
| 52-Week Low | 1.04 |
| Moving Average 50 Days | 1.57 |
| Moving Average 200 Days | 2.2 |
Statistics
| Average Volume | 924,147 |
| Shares Outstanding | 42.54M |
| % Held by Institutions | 38.97 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
